These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 9065578)
1. Renal involvement in myeloproliferative and lymphoproliferative disorders. A study of autopsy cases. Xiao JC; Walz-Mattmüller R; Ruck P; Horny HP; Kaiserling E Gen Diagn Pathol; 1997 Feb; 142(3-4):147-53. PubMed ID: 9065578 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study. Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A; Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608 [TBL] [Abstract][Full Text] [Related]
3. [The larynx in lymphoproliferative and myeloproliferative diseases. Part II: Laryngeal autopsy findings and discussion]. Horny HP HNO; 1994 Jul; 42(7):398-404. PubMed ID: 7928429 [TBL] [Abstract][Full Text] [Related]
4. [The value of multiparameter flow cytometry in diagnosis of lymphocytic leukemia and bone marrow involvement of non-Hodgkin's lymphoma]. Sun XF; He LR; Feng HL; Yan SL; Xia ZJ; Chen XQ Ai Zheng; 2003 Nov; 22(11):1232-6. PubMed ID: 14613660 [TBL] [Abstract][Full Text] [Related]
5. [The larynx in lymphoproliferative and myeloproliferative diseases. I: An overview with special reference to primary laryngeal malignant lymphomas and plasmacytomas]. Horny HP HNO; 1994 Jun; 42(6):334-9. PubMed ID: 8071093 [TBL] [Abstract][Full Text] [Related]
6. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture. Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of bone marrow sections in CLL. Urbano-Ispizua A; Montserrat E; Martí A; Feliu E; Vives-Corrons JL; Rozman C Nouv Rev Fr Hematol (1978); 1988; 30(5-6):325-6. PubMed ID: 3265503 [TBL] [Abstract][Full Text] [Related]
8. High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas. Bremer K J Cancer Res Clin Oncol; 2002 Nov; 128(11):603-9. PubMed ID: 12458340 [TBL] [Abstract][Full Text] [Related]
9. Incidence and pattern of liver involvement in haematological malignancies. Walz-Mattmüller R; Horny HP; Ruck P; Kaiserling E Pathol Res Pract; 1998; 194(11):781-9. PubMed ID: 9842637 [TBL] [Abstract][Full Text] [Related]
10. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients. Klobusická M; Kusenda J; Babusíková O Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061 [TBL] [Abstract][Full Text] [Related]
11. [Deep mycoses in leukemia and malignant lymphoma]. Donhuijsen K; Pfaffenbach B; Samandari S; Leder LD Verh Dtsch Ges Pathol; 1991; 75():214-7. PubMed ID: 1724836 [TBL] [Abstract][Full Text] [Related]
12. CNS involvement in leukaemia. An autopsy study of 100 consecutive patients. Bojsen-Møller M; Nielsen JL Acta Pathol Microbiol Immunol Scand A; 1983 Jul; 91(4):209-16. PubMed ID: 6575578 [TBL] [Abstract][Full Text] [Related]
13. Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas. Mazur G; Hałoń A; Wróbel T; Jeleń M; Kuliczkowski K Neoplasma; 2004; 51(3):159-63. PubMed ID: 15254666 [TBL] [Abstract][Full Text] [Related]
14. Adhesion molecule expression in CD5-negative/CD10-negative chronic B-cell leukemias: comparison with non-Hodgkin's lymphomas and CD5-positive B-cell chronic lymphocytic leukemia. Finn WG; Singleton TP; Schnitzer B; Ross CW; Stoolman LM Hum Pathol; 2001 Jan; 32(1):66-73. PubMed ID: 11172297 [TBL] [Abstract][Full Text] [Related]
15. [Autopsy results of deep mycoses in hematologic neoplasms (1053 patients]. Donhuijsen K; Pfaffenbach B; Samandari S; Leder LD Mycoses; 1991; 34 Suppl 1():25-7. PubMed ID: 1818257 [TBL] [Abstract][Full Text] [Related]
16. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases]. Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412 [TBL] [Abstract][Full Text] [Related]
17. Oral and salivary gland angiosarcoma: a clinicopathologic study of 29 cases. Fanburg-Smith JC; Furlong MA; Childers EL Mod Pathol; 2003 Mar; 16(3):263-71. PubMed ID: 12640107 [TBL] [Abstract][Full Text] [Related]
18. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Orazi A Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881 [TBL] [Abstract][Full Text] [Related]
19. Mobilisation of peripheral blood stem cells with IVE and G-CSF improves CD34+ cell yields and engraftment in patients with non-Hodgkin's lymphomas and Hodgkin's disease. McQuaker I; Haynes A; Stainer C; Byrne J; Russell N Bone Marrow Transplant; 1999 Oct; 24(7):715-22. PubMed ID: 10516673 [TBL] [Abstract][Full Text] [Related]